NORTH CHICAGO, Ill., May 22, 2018 /PRNewswire/ -- AbbVie, a research-based global biopharmaceutical company, today announced a donation of $100 million to two organizations, Direct Relief and Habitat for Humanity International, to strengthen access to healthcare and housing in Puerto Rico. The organizations will receive $50 million each. This donation is an extension of the more than $4 million AbbVie provided following the unprecedented natural disasters of 2017.
Spanish version available.
CHICAGO, Sept. 7, 2017 /PRNewswire/ -- AbbVie, a global biopharmaceutical company, achieved the top biotech industry sector ranking on the Dow Jones Sustainability Index (DJSI). Since AbbVie's founding in 2013, the company has been listed on both DJSI World and DJSI North America every year. DJSI is a leading global benchmark of 3,900 companies based on environmental, social and governance practices.
NORTH CHICAGO, Ill., June 26, 2017 /PRNewswire/ -- AbbVie, a global biopharmaceutical company, and its key partners celebrate the launch of the fourth annual "Week of Possibilities," with more than 6,000 employees expected to volunteer 26,000+ hours in the communities where they live and work. AbbVie volunteers will join forces with nonprofit partners like Heart of America Foundation and Points of Light, engaging in hands-on projects that largely focus on improving educational opportunities for children in underserved communities.
Stay up to date on recent news, articles, and more by subscribing to e-mail alerts for one or more of our news topics.
YOU ARE ABOUT TO LEAVE FOR A 3RD PARTY WEBSITE
Notice
The "Yes" link below will take you out of the AbbVie family of websites.
Links which take you out of the AbbVie worldwide websites are not under the control of AbbVie, and AbbVie is not responsible for the contents of any such site or any further links from such site. AbbVie is providing these links to you only as a convenience and the inclusion of any link does not imply endorsement of the linked site by AbbVie.
The Internet site that you have requested may not be optimized to your screen size.
Do you wish to leave this site?
